State Of New Jersey Common Pension Fund D Increased Stake in Lilly Eli & Co (LLY) as Shares Rose

June 27, 2018 - By Jacqueline McKee

Eli Lilly and Company (NYSE:LLY) Corporate LogoDuring Q1 2018 the big money sentiment decreased to 0.78. That’s change of 0.32, from 2017Q4’s 1.1. 76 investors sold all, 427 reduced holdings as LLY ratio dropped. 308 grew stakes while 82 funds bought stakes. Funds hold 810.94 million shares thus 1.95% less from 2017Q4’s 827.08 million shares. Fukoku Mutual Life Insurance holds 4,240 shs. Cypress Gp reported 1.32% in Eli Lilly and Company (NYSE:LLY). Osborne Ptnrs Cap Mgmt Ltd reported 0.04% of its capital in Eli Lilly and Company (NYSE:LLY). The Massachusetts-based Somerville Kurt F has invested 0.11% in Eli Lilly and Company (NYSE:LLY). Kornitzer Cap Management Incorporated Ks holds 286,947 shs. Ruggie Cap Gru has 0.01% invested in Eli Lilly and Company (NYSE:LLY) for 300 shs. Ww Asset Mgmt holds 66,784 shs or 0.24% of its capital. Mechanics Commercial Bank Department, a California-based fund reported 5,007 shs. Ballentine Lc reported 4,575 shs. Berkshire Asset Mngmt Lc Pa reported 0.11% stake. 11,439 were reported by Mitchell Sinkler & Starr Pa. Blue Cap owns 0.56% invested in Eli Lilly and Company (NYSE:LLY) for 12,804 shs. Hengehold Capital Mgmt Limited Co owns 0.07% invested in Eli Lilly and Company (NYSE:LLY) for 3,671 shs. Wellington Management Ltd Liability Partnership has invested 0.97% of its capital in Eli Lilly and Company (NYSE:LLY). Balyasny Asset Mgmt Lc invested in 143,519 shs or 0.05% of the stock.

LLY registered $92.69 million net activity with 1 buy and 19 insider sales since February 1, 2018. On Tuesday, May 1 Simmons Jeffrey N had sold 9,027 shs worth $708,620. On Monday, June 4 LILLY ENDOWMENT INC had sold 135,478 shs worth $11.53M. Another trade for 8,426 shs valued at $691,775 was made by Shaw Christi on Tuesday, May 29. Shares for $2.13 million were sold by Conterno Enrique A on Thursday, May 31. 22,544 shs valued at $1.81 million were sold by Mahony Susan on Friday, April 13. $237,600 worth of Eli Lilly and Company (NYSE:LLY) was sold by Smiley Joshua L on Friday, March 16.

The holdings In Lilly Eli & Co (LLY) was upped held by State Of New Jersey Common Pension Fund D. According to 2018Q1 Securities and Exchange filling the reduction is 3.04%. 60,000 shares were bought by State Of New Jersey Common Pension Fund D as the company’s stock rose 3.23% while stock markets declined. At the end of 2018Q1, the institutional investor held 2.03 million shares of the major pharmaceuticals company, priced at $157.25M, up from 1.97M at the end of the previous reported quarter. $86.95 billion is Lilly Eli & Co’s market cap. The stock increased 0.09% or $0.08 during the last trading session, touching $85.19.Currently Eli Lilly and Company is uptrending after 5.65% change in last June 27, 2017. LLY has 989,914 shares volume. The stock underperformed the S&P500 by 6.92%.

State Of New Jersey Common Pension Fund D manages about $25.99B US Long portfolio. Its stake in Colgate Palmolive Co (NYSE:CL) was decreased by 380,000 shares to 624,000 shares valued at $44.73 million in 2018Q1, according to the filing. State Of New Jersey Common Pension Fund D has cut its stake in Oneok Inc New (NYSE:OKE) and also reduced its holding in Salesforce Com Inc (NYSE:CRM) by 40,000 shares in the quarter, for a total of 330,300 shares.

A couple more Eli Lilly and Company (NYSE:LLY) news were announced by: Streetinsider.com which released on June 25, 2018 “Eli Lilly & Co. (LLY) Highlights New Data from Three Phase 1b Studies Evaluating URLi Compared to Humalog”, also Streetinsider.com on June 25, 2018 announced “Eli Lilly & Co. (LLY) Highlights Promise of Once-Weekly Trulicity (dulaglutide) in Data from Phase 2 study”, the next Fool.com is “Is Pfizer’s Lead Growth Driver in Trouble?” on June 26, 2018. Streetinsider.com has article titled “Boehringer Ingelheim, Lilly (LLY) Announce Phase III for Empagliflozin as Adjunct to Insulin in Type 1 Diabetes Met …”.

Eli Lilly and Company (NYSE:LLY) Ratings Coverage

Total analysts of 12 have positions in Eli Lilly (NYSE:LLY) as follows: 6 rated it a “Buy”, 1 with “Sell” and 5 with “Hold”. The positive are 50%. Since January 5, 2018 according to StockzIntelligence Inc Eli Lilly has 19 analyst reports. On Monday, February 26 the stock of Eli Lilly and Company (NYSE:LLY) has “Buy” rating given by Jefferies. On Friday, April 13 the stock of Eli Lilly and Company (NYSE:LLY) earned “Market Perform” rating by BMO Capital Markets. On Thursday, June 7 the company was initiated by Cantor Fitzgerald. On Friday, June 22 the company was downgraded by DZ Bank. The company rating was maintained by Leerink Swann on Thursday, February 1. On Monday, January 22 the rating was downgraded by Credit Suisse to “Underperform”. On Thursday, June 21 the company was maintained by Credit Suisse. On Thursday, February 1 Bank of America maintained the shares of LLY in report with “Neutral” rating. On Friday, January 5 Argus Research upgraded the shares of LLY in report to “Buy” rating. On Friday, March 23 Jefferies maintained Eli Lilly and Company (NYSE:LLY) with “Buy” rating.

Eli Lilly and Company (NYSE:LLY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.